TRAJENTA®: Favourable safety and tolerability for a broad range of patients.

TRAJENTA® has demonstrated a favourable safety and tolerability profile, with an incidence of adverse events similar to placebo.1

Please see the Summary of Product Characteristics for more information.

With one dose, once daily, TRAJENTA® can be prescribed regardless of disease duration, ethnicity, body mass index (BMI), liver and kidney function.1
Independent of:1


Want to understand more about the safety of TRAJENTA®?